Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial
Abstract Background Oxytocin is increasingly considered as a new pharmacological option for mitigating social difficulties and regulating stress in autism spectrum disorder. However, in prior trials, autistic individuals with co-occurring intellectual disability (ID) have largely been overlooked, de...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2025-03-01
|
| Series: | BMC Psychiatry |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12888-025-06617-6 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
